journal article·2020-09Open access

Enhanced Photothermal Therapy through the In Situ Activation of a Temperature and Redox Dual‐Sensitive Nanoreservoir of Triptolide

Hai‐Jun Liu, Mingming Wang, Xiangxiang Hu, Shanshan Shi, Peisheng Xu

Small· Volume 16· Issue 38

Abstract

Abstract Photothermal therapy (PTT) has attracted tremendous attention due to its noninvasiveness and localized treatment advantages. However, heat shock proteins (HSPs) associated self‐preservation mechanisms bestow cancer cells thermoresistance to protect them from the damage of PTT. To minimize the thermoresistance of cancer cells and improve the efficacy of PTT, an integrated on‐demand nanoplatform composed of a photothermal conversion core (gold nanorod, GNR), a cargo of a HSPs inhibitor (triptolide, TPL), a mesoporous silica based nanoreservoir, and a photothermal and redox di‐responsive polymer shell is developed. The nanoplatform can be enriched in the tumor site, and internalized into cancer cells, releasing the encapsulated TPL under the trigger of intracellular elevated glutathione and near‐infrared laser irradiation. Ultimately, the liberated TPL could diminish thermoresistance of cancer cells by antagonizing the PTT induced heat shock response via multiple mechanisms to maximize the PTT effect for cancer treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Natural Compounds in Disease Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Drug Discovery and Biomedical Sciences College of Pharmacy University of South Carolina 715 Sumter St. Columbia SC 29208 USA

Funding

National Institutes of Health

References (75)

Show source-provided references
1. 10.1039/C4NR01044B10.1039/C4NR01044B ↗
2. 10.1002/adma.20180259110.1002/adma.201802591 ↗
3. 10.1016/j.canlet.2008.04.02610.1016/j.canlet.2008.04.026 ↗
4. 10.1021/nn103047r10.1021/nn103047r ↗
5. 10.1002/adma.20140182510.1002/adma.201401825 ↗
6. 10.1002/adma.20140299610.1002/adma.201402996 ↗
7. 10.1002/adma.20110496410.1002/adma.201104964 ↗
8. 10.1021/acs.nanolett.8b0417910.1021/acs.nanolett.8b04179 ↗
9. 10.1021/nl051805d10.1021/nl051805d ↗
10. 10.1016/j.biomaterials.2015.05.04010.1016/j.biomaterials.2015.05.040 ↗
11. 10.1038/s41427-018-0040-710.1038/s41427-018-0040-7 ↗
12. 10.1002/advs.20160032710.1002/advs.201600327 ↗
13. 10.1002/smll.20190050110.1002/smll.201900501 ↗
14. 10.1080/0955300901455222110.1080/09553009014552221 ↗
15. 10.1007/978-94-007-4694-7_210.1007/978-94-007-4694-7_2 ↗
16. 10.1016/j.biomaterials.2013.12.04610.1016/j.biomaterials.2013.12.046 ↗
17. 10.1039/C4NR03753G10.1039/C4NR03753G ↗
18. 10.1016/j.biomaterials.2014.02.01810.1016/j.biomaterials.2014.02.018 ↗
19. 10.1016/j.biomaterials.2016.08.01610.1016/j.biomaterials.2016.08.016 ↗
20. 10.1002/anie.20100282010.1002/anie.201002820 ↗
21. 10.1016/j.addr.2015.12.01810.1016/j.addr.2015.12.018 ↗
22. 10.1002/adfm.20150491210.1002/adfm.201504912 ↗
23. 10.1038/ncomms1319310.1038/ncomms13193 ↗
24. 10.1002/advs.20170089110.1002/advs.201700891 ↗
25. 10.1146/annurev.ge.22.120188.00321510.1146/annurev.ge.22.120188.003215 ↗
26. 10.1146/annurev.ge.27.120193.00225310.1146/annurev.ge.27.120193.002253 ↗
27. 10.1016/j.tibs.2006.01.00610.1016/j.tibs.2006.01.006 ↗
28. 10.1016/j.canlet.2010.10.01410.1016/j.canlet.2010.10.014 ↗
29. 10.1016/j.tips.2016.11.00910.1016/j.tips.2016.11.009 ↗
30. 10.1074/jbc.272.50.3163610.1074/jbc.272.50.31636 ↗
31. 10.1016/S0014-5793(04)00158-910.1016/S0014-5793(04)00158-9 ↗
32. 10.1007/s11174-005-0036-410.1007/s11174-005-0036-4 ↗
33. 10.1111/j.1464-410X.2006.06425.x10.1111/j.1464-410X.2006.06425.x ↗
34. 10.1016/j.biomaterials.2016.06.01710.1016/j.biomaterials.2016.06.017 ↗
35. 10.1021/acsnano.6b0665810.1021/acsnano.6b06658 ↗
36. 10.1016/j.apsb.2018.05.01110.1016/j.apsb.2018.05.011 ↗
37. 10.1021/acsnano.6b0387410.1021/acsnano.6b03874 ↗
38. 10.1021/acsami.6b0811910.1021/acsami.6b08119 ↗
39. 10.1002/advs.20160032710.1002/advs.201600327 ↗
40. Luo H. · Adv. Funct. Mater. · 2017 · 27
41. 10.1242/jcs.06639910.1242/jcs.066399 ↗
42. 10.1038/nbt.329810.1038/nbt.3298 ↗
43. 10.3109/1042819010906458210.3109/10428190109064582 ↗
44. 10.2165/00126839-200304010-0000110.2165/00126839-200304010-00001 ↗
45. 10.1016/j.bcp.2006.08.02710.1016/j.bcp.2006.08.027 ↗
46. 10.1002/j.1939-4640.1998.tb02042.x10.1002/j.1939-4640.1998.tb02042.x ↗
47. 10.1158/0008-5472.CAN-07-107710.1158/0008-5472.CAN-07-1077 ↗
48. 10.1016/j.jss.2009.07.00210.1016/j.jss.2009.07.002 ↗
49. Meng C. · Chin. J. Cancer Res. · 2014 · 26 · 622
50. 10.1053/j.gastro.2010.04.04610.1053/j.gastro.2010.04.046 ↗
51. Li J. · Oncol. Rep. · 2011 · 25 · 979
52. Owa C. · Int. J. Women's Health · 2013 · 5 · 557
53. 10.1182/blood-2005-09-389810.1182/blood-2005-09-3898 ↗
54. 10.1038/sj.onc.120498110.1038/sj.onc.1204981 ↗
55. 10.1158/1535-7163.MCT-12-123110.1158/1535-7163.MCT-12-1231 ↗
56. 10.1074/jbc.M51204420010.1074/jbc.M512044200 ↗
57. 10.1074/jbc.M51204420010.1074/jbc.M512044200 ↗
58. 10.1016/j.biomaterials.2014.08.00410.1016/j.biomaterials.2014.08.004 ↗
59. 10.1002/anie.20130023910.1002/anie.201300239 ↗
60. 10.1002/adfm.20140275510.1002/adfm.201402755 ↗
61. 10.1002/adma.20120268710.1002/adma.201202687 ↗
62. 10.1021/nn502887j10.1021/nn502887j ↗
63. 10.1016/j.polymer.2013.08.02710.1016/j.polymer.2013.08.027 ↗
64. 10.1021/nn302842510.1021/nn3028425 ↗
65. 10.1002/smll.20140214510.1002/smll.201402145 ↗
66. Blanco M. · 2012
67. 10.2174/13892001079111082710.2174/138920010791110827 ↗
68. 10.1016/j.addr.2012.11.00610.1016/j.addr.2012.11.006 ↗
69. 10.1002/adma.20130189010.1002/adma.201301890 ↗
70. 10.1016/j.biocel.2012.03.00910.1016/j.biocel.2012.03.009 ↗
71. 10.1074/jbc.M113.50098310.1074/jbc.M113.500983 ↗
72. 10.1158/1535-7163.MCT-12-123110.1158/1535-7163.MCT-12-1231 ↗
73. Jiang J. X. · Am. J. Nucl. Med. Mol. Imaging · 2015 · 5 · 390
74. 10.18632/oncotarget.2473710.18632/oncotarget.24737 ↗
75. Xiong F. · 2006 · 4966